Volume 21 Issue 4
Aug.  2008
Turn off MathJax
Article Contents

JIAN-HUI YUAN, JIN-QUAN CHENG, LONG-YUAN JIANG, WEI-DONG JI, LIANG-FENG GUO, JIAN-JUN LIU, XING-YUN XU, JING-SONG HE, XIAN-MING WANG, ZHI-XIONG ZHUANG. Breast Cancer Resistance Protein Expression and 5-Fluorouracil Resistance[J]. Biomedical and Environmental Sciences, 2008, 21(4): 290-295.
Citation: JIAN-HUI YUAN, JIN-QUAN CHENG, LONG-YUAN JIANG, WEI-DONG JI, LIANG-FENG GUO, JIAN-JUN LIU, XING-YUN XU, JING-SONG HE, XIAN-MING WANG, ZHI-XIONG ZHUANG. Breast Cancer Resistance Protein Expression and 5-Fluorouracil Resistance[J]. Biomedical and Environmental Sciences, 2008, 21(4): 290-295.

Breast Cancer Resistance Protein Expression and 5-Fluorouracil Resistance

Funds:  国家重点基础研究发展规划(973计划)(2002CB512903)%国家自然科学基金(30500599)
  • To filtrate breast cancer resistance protein (BCRP)-mediated resistant agents and to investigate clinical relationship between BCRP expression and drug resistance. Methods MTT assay was performed to filtrate BCRP-mediated resistant agents with BCRP expression cell model and to detect chemosensitivity of breast cancer tissue specimens to these agents. A high performance liquid chromatography (HPLC) assay was established, and was used to measure the relative dose of intracellular retention resistant agents. RT-PCR and immununohistochemistry (IHC) were employed to investigate the BCRP expression in breast cancer tissue specimens. Results MTT assay showed that the expression of BCRP increased with the increasing resistance of 5-fluorouracil (5-Fu) (P<0.05, n=3) in the cell model, while HPLC assay indicated that the intracellular retention dose of 5-Fu was significantly correlated with the expression of BCRP (r=-0.897, P<0.05, n=3). A total of 140 breast cancer tissue specimens were collected. BCRP-positive expression was detected in forty-seven specimens by both RT-PCR and IHC. As shown by MTT MTT-ssay subsequently, the resistance index (RI) of 47 BCRP-positive breast cancer tissue specimens to 5-Fu was 7-12 times as high as that of adjacent normal tissue samples. BCRP expression was related to 5-Fu resistance (R<'2>=0.8124, P<0.01). Condusion Resistance to 5-Fu can be mediated by BCRP. Clinical chemotherapy for breast cancer patients can be optimized based on BCRP-positive expression.
  • 加载中
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(1141) PDF downloads(29) Cited by()

Proportional views
Related

Breast Cancer Resistance Protein Expression and 5-Fluorouracil Resistance

Funds:  国家重点基础研究发展规划(973计划)(2002CB512903)%国家自然科学基金(30500599)

Abstract: To filtrate breast cancer resistance protein (BCRP)-mediated resistant agents and to investigate clinical relationship between BCRP expression and drug resistance. Methods MTT assay was performed to filtrate BCRP-mediated resistant agents with BCRP expression cell model and to detect chemosensitivity of breast cancer tissue specimens to these agents. A high performance liquid chromatography (HPLC) assay was established, and was used to measure the relative dose of intracellular retention resistant agents. RT-PCR and immununohistochemistry (IHC) were employed to investigate the BCRP expression in breast cancer tissue specimens. Results MTT assay showed that the expression of BCRP increased with the increasing resistance of 5-fluorouracil (5-Fu) (P<0.05, n=3) in the cell model, while HPLC assay indicated that the intracellular retention dose of 5-Fu was significantly correlated with the expression of BCRP (r=-0.897, P<0.05, n=3). A total of 140 breast cancer tissue specimens were collected. BCRP-positive expression was detected in forty-seven specimens by both RT-PCR and IHC. As shown by MTT MTT-ssay subsequently, the resistance index (RI) of 47 BCRP-positive breast cancer tissue specimens to 5-Fu was 7-12 times as high as that of adjacent normal tissue samples. BCRP expression was related to 5-Fu resistance (R<'2>=0.8124, P<0.01). Condusion Resistance to 5-Fu can be mediated by BCRP. Clinical chemotherapy for breast cancer patients can be optimized based on BCRP-positive expression.

JIAN-HUI YUAN, JIN-QUAN CHENG, LONG-YUAN JIANG, WEI-DONG JI, LIANG-FENG GUO, JIAN-JUN LIU, XING-YUN XU, JING-SONG HE, XIAN-MING WANG, ZHI-XIONG ZHUANG. Breast Cancer Resistance Protein Expression and 5-Fluorouracil Resistance[J]. Biomedical and Environmental Sciences, 2008, 21(4): 290-295.
Citation: JIAN-HUI YUAN, JIN-QUAN CHENG, LONG-YUAN JIANG, WEI-DONG JI, LIANG-FENG GUO, JIAN-JUN LIU, XING-YUN XU, JING-SONG HE, XIAN-MING WANG, ZHI-XIONG ZHUANG. Breast Cancer Resistance Protein Expression and 5-Fluorouracil Resistance[J]. Biomedical and Environmental Sciences, 2008, 21(4): 290-295.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return